Nonalcoholic fatty liver disease with advanced fibrosis as a multi-systemic disease: proceed with caution

Affiliations

Editorial

Masato Yoneda et al. Hepatobiliary Surg Nutr. 2019 Apr.

. 2019 Apr;8(2):170-172.

doi: 10.21037/hbsn.2018.12.08.

¹ Department of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

No abstract available

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, Eslam M, Gonzalez-Fabian L, Alvarez-Quiñones Sanz M, Conde-Martin AF, De Boer B, McLeod D, Hung Chan AW, Chalasani N, George J, Adams LA, Romero-Gomez M. Vilar-Gomez E, et al. Gastroenterology. 2018 Aug;155(2):443-457.e17. doi: 10.1053/j.gastro.2018.04.034. Epub 2018 May 5. Gastroenterology. 2018. PMID: 29733831

1. Ludwig J, Viggiano TR, McGill DB, et al. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-8. - PubMed
1. Younossi ZM, Koenig AB, Abdelatif D, et al. Global Epidemiology of Nonalcoholic Fatty Liver Disease—Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes. Hepatology 2016;64:73-84. 10.1002/hep.28431 - DOI - PubMed
1. Ekstedt M, Hagstrom H, Nasr P, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology 2015;61:1547-54. 10.1002/hep.27368 - DOI - PubMed
1. Marchesini G, Bugianesi E, Forlani G, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-23. 10.1053/jhep.2003.50161 - DOI - PubMed
1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-31. 10.1056/NEJMra011775 - DOI - PubMed